Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Differentiation of Benign and Malignant Lesions of Prostate Using Radiomics Analysis

Authors

Soheila KoopaeeSoheila Koopaee ORCID1, Anahita Fathi Kazerooni1, Mahyar Ghafoori2, Mohamad Reza Alviri1, Kamal Hoseini1, Fakhereh Pashaei1, Hamidreza Saligheh Rad3,*
1Quantitative MR Imaging and Spectroscopy Group (QMISG), Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
2Department of Radiology, Iran University of Medical Sciences, Tehran, Iran
3Quantitative MR Imaging and Spectroscopy Group (QMISG), Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Quantitative MR Imaging and Spectroscopy Group (QMISG), Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran. Email: hamid.saligheh@gmail.com

Iranian Journal of Radiology:Vol. 16, issue Special Issue; e99135
Published online:Dec 10, 2019
Article type:Abstract
Received:Oct 26, 2019
Accepted:Dec 10, 2019
How to Cite:Koopaee S, Fathi Kazerooni A, Ghafoori M, Alviri MR, Hoseini K, et al. Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Differentiation of Benign and Malignant Lesions of Prostate Using Radiomics Analysis. I J Radiol. 2019;16(Special Issue):e99135. doi: https://doi.org/10.5812/iranjradiol.99135

Abstract

Background:

Prostate cancer is the second most common cancer-related cause of death in men. Accurate diagnosis of prostate cancer plays an important role in decreasing mortality rates. European Association of Urology (EAU) suggests multiparametric MRI (mp-MRI) of the prostate as a noninvasive method to evaluate prostate lesions. To leverage the interbreeder variability in the interpretation of mp-MRI, computer-aided diagnostic (CAD) systems can be used for automatic detection and characterization of prostate lesions.

Objectives:

The goal of this article was to design a quantification method based on mp-MRI for the discrimination of benign and malignant prostatic lesions with MR imaging/transrectal ultrasonography fusion-guided biopsy as a reference for pathology validation.

Methods:

Mp-MR images, including T1- and T2-weighted, diffusion-weighted imaging (DWI), and dynamic contrast enhancement imaging (DCE) MRI were acquired at 1.5T from 27 patients. Then, 106 radiomic features (first-order histogram (FOH), gray-level co-occurrence matrix (GLCM), run-length matrix (RLM), and Gabor filters) were calculated from mp-MRI. Statistical analysis was performed using receiver-operating-characteristic curve analysis for feature filtering, linear discriminant analysis (LDA) for feature extraction, and leave-one-out cross-validation for evaluation of the method in the differentiation of benign and malignant lesions.

Results:

An accuracy of 96.6% was achieved for discriminating benign and malignant prostate lesions from a subset of texture features derived from ADC and DCE maps (radiomics-based method) with sensitivity and specificity of 100% and 85.7%, respectively.

Conclusion:

A radiomic quantification method based on T2-weighted images, ADC maps, and quantitative and semiquantitative DCE maps can discriminate benign from malignant prostate lesions with promising accuracy. This method is helpful to avoid unnecessary biopsies in patients and may provide information for CAD systems for the classifications of prostate lesions as an auto-detection technique.

Highlights

Copyright

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

3
Oct
2016
Multiparametric Magnetic Resonance Imaging of Prostate Cancer: Association of Quantitative Magnetic Resonance Parameters with Histopathologic Findings

Multiparametric Magnetic Resonance Imaging of Prostate Cancer: Association of Quantitative Magnetic Resonance Parameters with Histopathologic Findings

Iraj Abedi,
Mohammad Bagher Tavakkoli,
Masoud Rabbani,
Keyvan Jabbari,
Mehri Sirous,
Ghasem Yadegar Far

Abedi I, Tavakkoli MB, Rabbani M, Jabbari K, Sirous M, et al. Multiparametric Magnetic Resonance Imaging of Prostate Cancer: Association of Quantitative Magnetic Resonance Parameters with Histopathologic Findings. I J Radiol. 2017;14(3):e37844. doi: https://doi.org/10.5812/iranjradiol.37844

11
Sep
2023
The Prevalence of Prostate Cancer in Biopsy Samples of Lesions with PI-RADS 2 Score in Multiparametric Magnetic Resonance Imaging: A Cross-sectional Study

The Prevalence of Prostate Cancer in Biopsy Samples of Lesions with PI-RADS 2 Score in Multiparametric Magnetic Resonance Imaging: A Cross-sectional Study

Hossein Karami,
Mahyar Ghafoori,
Reza Dashti

Karami H, Ghafoori M, Dashti R. The Prevalence of Prostate Cancer in Biopsy Samples of Lesions with PI-RADS 2 Score in Multiparametric Magnetic Resonance Imaging: A Cross-sectional Study. Int J Cancer Manag. 2023;16(1):e132340. doi: https://doi.org/10.5812/ijcm-132340

7
Aug
2019
Level of Prostate Cancer Diagnosis Using MRI-TRUS Fusion Biopsy in Patients with a Negative History of TRUS Biopsy

Level of Prostate Cancer Diagnosis Using MRI-TRUS Fusion Biopsy in Patients with a Negative History of TRUS Biopsy

Alireza Lashey,
Said Yaghoob Sehri,
Ahmad Aghai Meibodi,
Mahyar Ghafari,
Jafar Gholivandan,
Mohamad Solymani
,et al.

Lashey A, Sehri SY, Aghai Meibodi A, Ghafari M, Gholivandan J, et al. Level of Prostate Cancer Diagnosis Using MRI-TRUS Fusion Biopsy in Patients with a Negative History of TRUS Biopsy. Nephro-Urol Mon. 2019;11(3):e93596. doi: https://doi.org/10.5812/numonthly.93596

23
Dec
2017
PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values

PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values

Kunwarpal Singh,
Kamlesh Gupta,
C. L. Thukral,
Priya Goyal,
Vijinder Arora,
Inderbir Singh

Singh K, Gupta K, Thukral CL, Goyal P, Arora V, et al. PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values. I J Radiol. 2018;15(1):e14038. doi: https://doi.org/10.5812/iranjradiol.14038

2
Oct
2018
Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) as a Diagnostic Method for Prostate Cancer

Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) as a Diagnostic Method for Prostate Cancer

Mohsen Sarkarian,
Alireza Kheradmand,
Hamed Haghiabi,
Mohammad Kolbadinezhad

Sarkarian M, Kheradmand A, Haghiabi H, Kolbadinezhad M. Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) as a Diagnostic Method for Prostate Cancer. Nephro-Urol Mon. 2018;10(6):e82856. doi: https://doi.org/10.5812/numonthly.82856

More by these authors

Soheila KoopaeePubMedScholar
Anahita Fathi KazerooniPubMedScholar
Mahyar GhafooriPubMedScholar
Mohamad Reza AlviriPubMedScholar
Kamal HoseiniPubMedScholar
Fakhereh PashaeiPubMedScholar
Hamidreza Saligheh RadPubMedScholar
Share
Cited by
Metrics